Blog Posts

Yat Kiralama

Posted by Web Hizmetleri on March 28, 2024 at 7:49pm 0 Comments

Yat kiralama fiyatları ne kadar? Makalemizde sizler için bahsedeceğiz. Yat kiralama, lüks ve keyifli bir deneyim sunarken, fiyatların nasıl belirlendiği birçok kişi tarafından merak edilir. Yat kiralama fiyatları, birkaç faktöre bağlı olarak değişebilir ve doğru bir fiyatlandırma için dikkate alınması gereken bazı önemli faktörler vardır.

Yat Kiralama Fiyatlarını Etkileyen…

Continue

Growing Connections The Eco Friendly Impact of Seed Paper Business Cards

Posted by LittleGreenPaperShop on March 28, 2024 at 7:36pm 0 Comments

Seed paper business cards are exactly what they sound like – paper embedded with seeds. This unique paper is crafted from recycled materials like post-consumer waste and cotton fibers, making it biodegradable and environmentally friendly. The seeds embedded within the paper can vary, ranging from wildflowers and herbs to vegetables, depending on the desired outcome. When planted in soil and given proper care, these seeds germinate, sprouting new life from what…

Continue

Top Slot Games and Sites: Singapore's Online Betting Gems

Posted by EZ12bet on March 28, 2024 at 7:14pm 0 Comments

In the vibrant city-state of Singapore, where entertainment and technology intersect seamlessly, online betting sites have become a popular avenue for thrill-seekers and gaming enthusiasts alike. Among the plethora of options available, slot games stand out as a perennial favorite, offering a perfect blend of simplicity, excitement, and potential rewards. Let's delve into the realm of online betting and explore the allure of…

Continue

Exenatide, powder for injection, 2 mg, Bydureon

Exenatide, powder for injection, 2 mg, Bydureon

1. Purpose of Application
The major re-submission requested listing of a 2 mg once weekly formulation for the treatment of Type 2 diabetes as:Exenatide acetate powder,Exenatide powder

1) Dual combination therapy with metformin or a sulfonylurea in a patient who meets certain criteria; and

2) Triple combination therapy with metformin and a sulfonylurea in a patient who meets certain criteria.

2. Background
This was the third consideration by the PBAC of the once weekly formulation. Exenatide 5 mcg and 10 mcg (twice daily) have been PBS listed since 1 August 2010.

The Public Summary Document for a submission rejected by the PBAC in July 2011 is available on the PBS website.

At the July 2013 meeting, the PBAC rejected a minor submission for exenatide once weekly injection on the basis of no new data presented to support the claims of comparative effectiveness and safety and unclear cost-offsets.

3. Registration Status
Exenatide 2 mg powder for injection was registered by the TGA on 20 December 2012 for:

The treatment of type 2 diabetes mellitus in combination with metformin; or sulfonylureas; or metformin and a sulfonylurea in patients who have not achieved adequate glycaemic control.
4. Listing Requested and PBAC’s View
The requested listing was unchanged from the previous submission:

Authority required (STREAMLINED)

Dual combination therapy with metformin or a sulfonylurea.

Type 2 diabetes, in combination with either metformin or a sulfonylurea, in a patient whose HbA1c is greater than 7% prior to initiation of a dipeptidyl peptidase 4 inhibitor (gliptin), a thiazolidinedione (glitazone) or a glucagon-like peptide-1 despite treatment with either metformin or a sulfonylurea and where a combination of metformin and a sulfonylurea is contraindicated or not tolerated.

Triple combination therapy with metformin and a sulfonylurea.

Type 2 diabetes, in combination with metformin and a sulfonylurea, in a patient whose HbA1c is greater than 7% prior to initiation of a dipeptidyl peptidase 4 inhibitor (gliptin), a thiazolidinedione (glitazone) or a glucagon-like peptide-1 despite treatment with maximally tolerated doses of metformin and a sulfonylurea

Views: 19

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service